Andrew Fromkin
Director/Miembro de la Junta en IMMUNOVANT, INC. .
Fortuna: 3 M $ al 31/05/2024
Origen de la red de primer grado Andrew Fromkin.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Biotechnology | 28 | |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY.
26
| Subsidiary | Pharmaceuticals: Major | 26 |
Clinical Data, Inc.
 Clinical Data, Inc. Medical SpecialtiesHealth Technology Clinical Data, Inc. manufactured and distributed scientific instruments used in clinical and analytical laboratories. The company was founded in 1972 and was headquartered in Newton, MA.
21
| Extinct | Medical Specialties | 21 |
| Subsidiary | Pharmaceuticals: Major | 14 | |
Merck-Medco Managed Care LLC
 Merck-Medco Managed Care LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck-Medco Managed Care LLC discovers, develops, and markets a broad range of human and animal health products. The company is based in Whitehouse Station, NJ.
9
| Subsidiary | Pharmaceuticals: Major | 9 |
Tarveda Therapeutics, Inc.
 Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Tarveda Therapeutics, Inc. discovers and develops cancer therapeutics and drugs. Its proprietary technology, assets and expertise are built around an integrative research and development process that brings together new-molecule drug discovery engine and patented nanoparticle engineering platform. The company was founded by Omid C. Farokhzad, Stephen J. Lippard and Robert S. Langer Jr., in 2011 and is headquartered in Watertown, MA.
8
| Extinct | Biotechnology | 8 |
Regado Biosciences, Inc.
 Regado Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Regado Biosciences, Inc. is a biopharmaceutical company, which engages in the discovery and development of therapies in cardiovascular medicine using actively controlled aptamer technology. The company is focusing on new products for antithrombotic indications in the acute care and sub-acute care therapeutic setting. Its paired aptamer-active control agent technology is designed to give physicians the ability to directly control the degree of antithrombotic activity in real time on a "per patient, per setting" basis. The company's clinical programs are specifically concentrated on acute and sub-acute care injectable anticoagulants. Regado Biosciences was founded by Eli Gilboa, Bruce A. Sullenger and Christopher P. Rusconi on December 19, 2001 and is headquartered in Basking Ridge, NJ.
8
| Extinct | Pharmaceuticals: Major | 8 |
Immunovant Sciences Ltd.
 Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million.
5
| Subsidiary | Biotechnology | 5 |
DoctorQuality, Inc.
 DoctorQuality, Inc. Medical DistributorsDistribution Services DoctorQuality, Inc. provides medical equipment. The American company was founded by David J. Shulkin.
1
| Private Company | Medical Distributors | 1 |
| Holding Company | Biotechnology | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Andrew Fromkin a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Human Resources Officer Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Treasurer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Carnegie Mellon University
 Carnegie Mellon University Other Consumer ServicesConsumer Services Carnegie Mellon University is an American school that operates as a college or university. It is located in Pittsburgh, Pennsylvania. | College/University | Graduate Degree Graduate Degree Graduate Degree | |
| AVANIR PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Investor Relations Contact | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor Corporate Officer/Principal Comptroller/Controller/Auditor | |
| SIO GENE THERAPIES INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chairman Chief Executive Officer Director/Board Member Director/Board Member | |
| ROIVANT SCIENCES LTD. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer Chairman Comptroller/Controller/Auditor Chief Executive Officer President Director of Finance/CFO | |
| MYOVANT SCIENCES LTD. | Biotechnology | Director/Board Member Chairman Director/Board Member Director/Board Member Chairman Director/Board Member Director/Board Member | |
| SYNDAX PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer Chairman Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| Yale University | College/University | Undergraduate Degree Graduate Degree Graduate Degree Masters Business Admin Doctorate Degree | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman Chairman Director/Board Member | |
| UROVANT SCIENCES LTD. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| PRECIGEN, INC. | Biotechnology | Chairman Director/Board Member Director/Board Member Private Equity Investor | |
| MIRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
Dermavant Sciences, Inc.
 Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Chairman | |
New River Pharmaceuticals, Inc.
 New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member Corporate Officer/Principal | |
Dermavant Sciences Ltd.
 Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company which focuses on developing and commercializing therapeutics in medical dermatology. The company is developing a pipeline of therapies in medical dermatology and is currently advancing development programs for five product candidates which targets specific unmet needs in two of the immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne. The company was founded on September 28, 2015 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Chairman | |
| The University of Chicago | College/University | Masters Business Admin Director/Board Member Masters Business Admin Undergraduate Degree | |
| ALLERGAN PLC | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| University of Pennsylvania | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Urovant Sciences, Inc.
 Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
| CAREDX, INC | Medical Specialties | Director/Board Member Director/Board Member Director of Finance/CFO | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
Medco Health Solutions, Inc.
 Medco Health Solutions, Inc. Medical/Nursing ServicesHealth Services Medco Health Solutions, Inc. retails drugs, pharmaceuticals and other health products through online. The firm provides pharmacy services which are designed for private and public employers, health plans, labor unions government agencies of all sizes and individuals. The company was founded in June 1983 and is headquartered in Franklin Lakes, NJ. | Medical/Nursing Services | Chairman Director/Board Member Corporate Officer/Principal | |
| The Wharton School of the University of Pennsylvania | College/University | Graduate Degree Masters Business Admin Undergraduate Degree | |
Axovant Sciences, Inc.
 Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer | |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
| VITAE PHARMACEUTICALS INC | Pharmaceuticals: Major | President Treasurer Corporate Secretary | |
| Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
Cerexa, Inc.
 Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Cerexa, Inc. develops biopharmaceutical products. It is focuses on developing, acquiring and commercializing antibiotics to treat life-threatening, hospital-based infections. Cerexa's compound PPI-0903 is a cephalosporin used in treatment for complicated skin and skin-structure infections, as well as community-acquired and hospital-acquired pneumonias. The company was founded in 2005 and is headquartered in Alameda, CA. | Pharmaceuticals: Major | Chairman Director/Board Member Founder | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Allergan GI Corp.
 Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | Biotechnology | President Treasurer Corporate Secretary | |
| ALAUNOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Operating Officer Chairman | |
Sumitovant Biopharma, Inc.
 Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sumitovant Biopharma, Inc. provides biotechnology services. It offers oncology, gene therapy, rare, pulmonary, urological disease, digital innovation and novel platforms. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member | |
Third Security LLC
 Third Security LLC Investment ManagersFinance Third Security LLC (Third Security) is a private equity firm founded in 1999 by Randal J. Kirk. The firm is headquartered in Radford, Virginia. | Investment Managers | Chief Executive Officer Private Equity Investor Private Equity Analyst | |
| ADYNXX, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
| The Pennsylvania State University | College/University | Graduate Degree Undergraduate Degree Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 43 |
| Reino Unido | 5 |
| China | 2 |
| Irlanda | 2 |
| Países Bajos | 2 |
Sectorial
| Health Technology | 35 |
| Consumer Services | 12 |
| Finance | 3 |
| Commercial Services | 2 |
| Health Services | 2 |
Operativa
| Director/Board Member | 614 |
| Corporate Officer/Principal | 218 |
| Independent Dir/Board Member | 176 |
| Chairman | 121 |
| Director of Finance/CFO | 109 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Eckard Weber | 46 |
| Pierre Legault | 45 |
| Raphaël Wisniewski | 45 |
| G. Steven Burrill | 44 |
| Patrick Heron | 42 |
| Myrtle Potter | 41 |
| George Bickerstaff | 37 |
| Frank Torti | 35 |
| Ambrose Bailey | 32 |
| Clarence Machado | 30 |
| Sandra Peterson | 28 |
| Dennis Podlesak | 27 |
| Kenneth Ludlum | 24 |
| Joseph Klein | 24 |
| Laurent Fischer | 23 |
- Bolsa de valores
- Insiders
- Andrew Fromkin
- Conexiones Empresas
